secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001380106-23-000142
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Q2 revenue $5.0M (+30% YoY); net loss $14.0M; reaffirms FY2023 guidance
-----------------------------------------------------------------------

- Total revenue $5.0M, up 30% from $3.9M in Q2 2022; net loss $14.0M ($0.33 per share) vs $13.1M ($0.31).
- Recurring revenue $3.6M, up 44% YoY; record consumable revenue; placed two new Growth Direct systems.
- Cash, cash equivalents and investments $113.3M as of June 30, 2023; no debt; cash runway into 2026.
- Reaffirmed FY2023 revenue guidance of at least $22.0M (~30% growth) and at least 15 system placements.
- Appointed Kirk Malloy, Ph.D. as Chair of the Board of Directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010623000142/0001380106-23-000142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010623000142/rpid-20230804.htm
  HTML page:      https://secwatch.observer/filing/0001380106-23-000142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer